Medetomidine and atipamezole in sheep: disposition and clinical effects.
Ranheim
B
B
Department of Pharmacology, Microbiology and Food Hygiene, The Norwegian School of Veterinary Science, PO Box 8146 Dep., N-0033 Oslo, Norway. birgit.ranheim@veths.no
Arnemo
J M
JM
Stuen
S
S
Horsberg
T E
TE
D000316:Adrenergic alpha-Agonists / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D000818:Animals; D019540:Area Under Curve; D002851:Chromatography, High Pressure Liquid; D016292:Procedural Sedation; D018592:Cross-Over Studies; D004334:Drug Administration Schedule; D004347:Drug Interactions; D005260:Female; D006207:Half-Life; D007093:Imidazoles / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D007275:Injections, Intravenous; D020926:Medetomidine / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D008657:Metabolic Clearance Rate; D012756:Sheep
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D007093:Imidazoles; C050701:atipamezole; D020926:Medetomidine